Fabio Aglieco is a Nephrology physician. OpenAlex indexes 9 publications with 570 citations (h-index 5).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
513 S Columbia Dr
West Columbia, TX 774863025
Telephone
979-345-6522Provider last certified this registry record 30 Mar 2023.
Industry payments
12 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- AKEBIA THERAPEUTICS INCProgram year20253 payments
- Novartis Pharmaceuticals CorporationProgram year20252 payments
- Travere Therapeutics, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
42.6%Statin7.6%Atorvastatin Calcium55%Rosuvastatin Calcium25%Pravastatin Sodium10%Simvastatin5%Lovastatin4%Part D<11 patientsBeta blocker7.1%Carvedilol47%Metoprolol Succinate22%Metoprolol Tartrate12%Atenolol10%Nebivolol Hcl4%Bisoprolol-Hydrochlorothiazide3%Propranolol Hcl Er2%Part D<11 patients+ 17 more classes in this area
Metabolism & gastrointestinal
18.7%GLP-1 receptor agonist3.4%Mounjaro49%Ozempic46%Trulicity5%Part D<11 patientsBiguanide (metformin)3.3%Metformin Hcl Er59%Metformin Hcl41%Part D≥60 patients+ 16 more classes in this area
Nervous system
15.4%Benzodiazepine2.9%Alprazolam42%Diazepam20%Lorazepam18%Clonazepam12%Temazepam7%Part D<11 patientsGabapentinoids2.9%Gabapentin93%Pregabalin7%Part D<11 patients+ 17 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Case Report of Refractory Warm Autoimmune Hemolytic Anemia Treated With Plasmapheresis and Rituximab
Therapeutic Apheresis and Dialysis
2008 - 3: Expanded Plasma Volume in Waldenstrom’s Macroglobulinemia as Evidenced by IGM Reduction Ratios During Therapeutic Plasma Exchange (TPE)
American Journal of Kidney Diseases
2008 - 55: Minimal Change Disease (MCD) Presenting as Acute Kidney Injury and Nephrotic-Range Proteinuria Without Edema
American Journal of Kidney Diseases
2008 - Critical Molecular Determinants of Voltage-Gated Sodium Channel Sensitivity to μ-Conotoxins GIIIA/B
Molecular Pharmacology
2002
Similar KOLs
Other experts from the same institution or the same specialty.
Giuseppe Remuzzi
Mario Negri Institute for Pharmacological Research
Marcello Tonelli
University of Calgary
Johan Ärnlöv
Dalarna University
Juan Jesús Carrero
Danderyds sjukhus
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”